Nexperia’s China Unit ‘Nears Fully Local Production’ of Chips

Key Takeaways

• Nexperia China targets 90% capacity Q2 2024.
• Full localisation expected by late 2026.
• Dutch restrictions forced shift to domestic wafers.
• Automotive chip supply may stabilize in China.
• Ongoing Dutch‑China dispute hampers corporate collaboration.

Summary

Nexperia’s China unit is close to achieving full local chip production, having shifted from European wafer imports after Dutch restrictions. The plant in Dongguan and a new wafer fab in Shanghai are operating at 60‑70% capacity and aim to reach 90% by Q2 2024. Full localisation of most products, including automotive chips, is targeted for the second half of 2026. The move underscores the broader Dutch‑China dispute over technology transfer and supply‑chain security.

Pulse Analysis

The Nexperia saga illustrates how geopolitical friction can force rapid restructuring of semiconductor supply chains. After the Dutch government invoked a Cold‑War‑era law to seize control of the Dutch‑headquartered, China‑owned chipmaker, the firm cut off wafer shipments to its Chinese unit. In retaliation, Beijing imposed export controls, prompting Nexperia China to accelerate domestic wafer production. This pivot reflects a broader trend where companies under political pressure develop parallel manufacturing capabilities to safeguard market access.

Nexperia’s Chinese operations have already repurposed its Dongguan packaging line and launched a 12‑inch wafer fab in Shanghai, currently running at 60‑70% of design capacity using stockpiled and locally sourced wafers. The company projects a surge to 90% capacity by the second quarter of 2024, with full localisation of its automotive‑grade chips by late 2026. For car manufacturers that rely on Nexperia’s power‑semiconductor portfolio, the shift promises a more reliable supply, reducing the risk of production cuts that have plagued the industry amid recent chip shortages.

The broader implication for the semiconductor sector is a growing incentive to diversify manufacturing footprints away from single‑source dependencies. As Western regulators tighten technology‑transfer rules, Chinese firms are bolstering domestic capabilities, while European and U.S. players must weigh the cost of restricting access against the loss of market share. Nexperia’s experience may serve as a case study for other multinational chipmakers navigating the delicate balance between compliance, geopolitical risk, and the need to maintain uninterrupted supply to critical downstream industries.